160 related articles for article (PubMed ID: 3158269)
1. Reversal of cardiac hypertrophy by medical treatment.
Tarazi RC; Fouad FM
Annu Rev Med; 1985; 36():407-14. PubMed ID: 3158269
[TBL] [Abstract][Full Text] [Related]
2. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
Klaus D
Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
[TBL] [Abstract][Full Text] [Related]
3. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
Ruskoaho H
Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
[TBL] [Abstract][Full Text] [Related]
4. Reversal of cardiac hypertrophy in humans.
Tarazi RC; Fouad FM
Hypertension; 1984; 6(6 Pt 2):III140-6. PubMed ID: 6240447
[TBL] [Abstract][Full Text] [Related]
5. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
Friberg P
Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
[TBL] [Abstract][Full Text] [Related]
6. Coronary reserve in experimental myocardial hypertrophy.
Gosse P; Clementy J
Eur Heart J; 1995 Aug; 16 Suppl I():22-5. PubMed ID: 8829953
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
Strauer BE
Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
[TBL] [Abstract][Full Text] [Related]
8. Is reversal of cardiac hypertrophy a desirable goal of antihypertensive therapy?
Tarazi RC; Frohlich ED
Circulation; 1987 Jan; 75(1 Pt 2):I113-7. PubMed ID: 2947744
[TBL] [Abstract][Full Text] [Related]
9. Regression of left ventricular hypertrophy by medical treatment: present status and possible implications.
Tarazi RC
Am J Med; 1983 Sep; 75(3A):80-6. PubMed ID: 6226199
[TBL] [Abstract][Full Text] [Related]
10. Medical repair of hypertensive left ventricular remodeling.
Motz WH; Scheler S; Strauer BE
J Cardiovasc Pharmacol; 1992; 20 Suppl 1():S32-6. PubMed ID: 1380616
[TBL] [Abstract][Full Text] [Related]
11. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
Strauer BE; Bayer F; Brecht HM; Motz W
J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
[TBL] [Abstract][Full Text] [Related]
12. [Coronary flow in experimental cardiac hypertrophy caused by arterial hypertension].
Wicker P; Tarazi R; Dallocchio M; Bricaud H
Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():133-6. PubMed ID: 6214231
[TBL] [Abstract][Full Text] [Related]
13. [Antihypertensive treatment and remission of left ventricular hypertrophy. Critical study].
Clémenty J; Dulhoste MN; Bordier P; Lartigue MC; Pons N
Arch Mal Coeur Vaiss; 1990 Dec; 83 Spec No 4():39-43. PubMed ID: 2150473
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of myocardial and coronary effects of arterial hypertension].
Strauer BE; Motz W; Vogt M
Z Kardiol; 1989; 78 Suppl 7():231-8. PubMed ID: 2533767
[TBL] [Abstract][Full Text] [Related]
15. Therapy of hypertensive cardiac hypertrophy and impaired coronary microcirculation.
Motz W; Strauer BE
J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S34-8. PubMed ID: 7533225
[TBL] [Abstract][Full Text] [Related]
16. Cardiac determinants of regression of left ventricular hypertrophy in essential hypertension with antihypertensive treatment.
Sugishita Y; Iida K; Yukisada K; Ito I
J Am Coll Cardiol; 1990 Mar; 15(3):665-71. PubMed ID: 2137479
[TBL] [Abstract][Full Text] [Related]
17. Adrenergic activity and myocardial anatomy and function in essential hypertension.
Muiesan G; Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1985 Dec; 3(4):S45-50. PubMed ID: 3007705
[TBL] [Abstract][Full Text] [Related]
18. Coronary vascular changes in the progression and regression of hypertensive heart disease.
Strauer BE; Schwartzkopff B; Motz W; Vogt M
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S20-7. PubMed ID: 1720480
[TBL] [Abstract][Full Text] [Related]
19. Effect of manidipine on cardiac hypertrophy and coronary circulation in DOCA/salt hypertensive rats.
Takeda K; Nakata T; Kuwabara T; Itoh H; Yamahara Y; Takesako T; Tanabe S; Sasaki S; Asayama J; Nakagawa M
Blood Press Suppl; 1992; 3():48-52. PubMed ID: 1343289
[TBL] [Abstract][Full Text] [Related]
20. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
